Predictive Technology Group Inc (PRED)

[zugisland]

he Company introduced the Assurance VR COVID-19 RT-PCR test in July 2020. The Assurance VR COVID-19 viral test is intended for the qualitative detection of SARS-CoV-2 coronavirus during the acute phase of COVID-19 infection. Assurance VR is intended for individuals suspected of COVID-19 infection by a healthcare provider. Assurance VR uses a saliva sample to detect the presence of the SARS-CoV-2 coronavirus genetic material (RNA) using a process called RT-PCR. The sample is processed and results delivered by Predictive Laboratories, a high-complexity CLIA laboratory. Assurance VR uses the EUA approved Thermo Fisher TaqPath COVID-19 Combo Kit for the detection of the SARS-CoV-2 virus. Assurance VR samples are collected using an EUA approved at-home saliva sample collection kit produced by Spectrum Solutions, LLC. This collection device is easier, less intrusive and safer for health care workers than nasopharyngeal or oropharyngeal swabs.